From H+Pedia
Jump to navigation Jump to search

RejuverSen is a Swiss biotech startup developing therapies to clear senescent (aged) cells that are created after chemotherapy.[1][2] The company is part of Rejuveron's investment portfolio.[2][3]


  1. "RejuverSen". Rejuveron. Retrieved 28 April 2021. "Residual senescent cells generated after cancer chemotherapy also favor cancer recurrence. We have discovered a novel way by which senescent cells evade the immune system and we are developing therapies specifically targeting that mechanism."
  2. 2.0 2.1 "Rejuversen". Longevity List. Retrieved 28 April 2021. "Clearance of chemotherapy-induced senescent cells."
  3. "About us". Rejuveron. Retrieved 28 April 2021.

External links